Coronal craniosynostosis bilateral
ICD-10 Q75.022 is a billable code used to indicate a diagnosis of coronal craniosynostosis bilateral.
Coronal craniosynostosis bilateral is a congenital condition characterized by the premature fusion of the coronal sutures on both sides of the skull. This fusion restricts the growth of the skull in the affected areas, leading to an abnormal head shape, often described as a 'tower skull' or 'frontal bossing.' The condition can result in increased intracranial pressure, developmental delays, and facial asymmetry. Diagnosis typically involves physical examination and imaging studies such as CT scans to assess the skull shape and rule out associated anomalies. Treatment usually requires surgical intervention to correct the skull shape and allow for normal brain growth. Early diagnosis and management are crucial to prevent complications and support optimal neurodevelopment. The condition may be isolated or associated with syndromic presentations, necessitating a comprehensive evaluation for other congenital malformations.
Pediatric documentation must include growth parameters, developmental milestones, and any associated symptoms or anomalies.
Common scenarios include referrals for abnormal head shape, developmental delays, and preoperative assessments for surgical correction.
Considerations include the age of the child, potential for neurodevelopmental impact, and the need for ongoing monitoring.
Genetic documentation should include family history, potential syndromic associations, and results from genetic testing if performed.
Scenarios may involve genetic counseling for families with a history of craniosynostosis or related syndromes.
Considerations include the identification of syndromic forms of craniosynostosis and implications for family planning.
Used in surgical correction of craniosynostosis.
Operative report detailing the procedure and indications.
Pediatric surgical documentation must include preoperative assessments and postoperative follow-up.
Accurate coding of Q75.022 is crucial for ensuring appropriate treatment, reimbursement, and tracking of congenital conditions. It helps in identifying the prevalence of craniosynostosis and associated anomalies, guiding clinical management and research.
